Join now and help us get AHEAD of Alzheimer’s!

The AHEAD Study is testing an investigational treatment aimed at maintaining normal memory and thinking in adults at higher risk.

AHEAD Study Information Session

Learn more and ask questions about the AHEAD study while also learning more about Alzheimer’s disease risk.

Fall/Winter Information Session dates coming soon!
To learn more about the AHEAD study please call 401-455-6402 or e-mail memory@butler.org

Purpose

To determine if the investigational treatment BAN2401 is superior to a placebo in terms of maintaining normal cognitive (memory and thinking) abilities, and how effective it is in reducing levels of amyloid and tau plaques in the brain associated with the development of Alzheimer’s disease.

Process

Eligible participants will be randomly assigned to one of two groups: one that will receive the investigational medication, BAN2401, or one that will receive a placebo.
Participants will be monitored for 4 years.

Eligibility

Men and women ages 55 – 80
Cognitively normal
Have a partner to accompany you to study appointments

To learn more information visit https://www.butler.org/studies/ahead-study